Kura Oncology (KURA) Short term Debt (2015 - 2025)

Kura Oncology (KURA) has 8 years of Short term Debt data on file, last reported at $4.3 million in Q3 2025.

• Short term Debt for Q3 2025 came in at $4.3 million, up 152.89% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.3 million (up 152.89% YoY), and the FY2024 annual result was $2.6 million, changed N/A from the prior year.
• Short term Debt rose to $4.3 million in Q3 2025 per KURA's latest filing, from $3.1 million in the prior quarter.
• Over five years, Short term Debt peaked at $4.3 million in Q3 2025 and troughed at $847000.0 in Q2 2024.
• A 3-year average of $2.5 million and a median of $2.6 million in 2024 frame the typical range for Short term Debt.
• On a YoY basis, Short term Debt climbed as much as 267.41% in 2025 and fell as far as 152.89% in 2025.
• A 3-year view of Short term Debt shows it stood at $3.0 million in 2021, then retreated by 13.1% to $2.6 million in 2024, then soared by 66.36% to $4.3 million in 2025.
• Business Quant data shows KURA's Short term Debt at $4.3 million in Q3 2025, $3.1 million in Q2 2025, and $1.9 million in Q1 2025.